Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Total article views   HTML views PDF downloads Totals
10,561 Dovepress* 9,679+ 1,872 11,551
PubMed Central* 882 408 1,290
Totals 10,561 2,280 12,841
*Since 16 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
24 0 0 0 12 12

View citations on PubMed Central and Google Scholar